Brevan Howard Capital Management’s Aehr Test Systems AEHR Stock Holding History

Brevan Howard Capital Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Sell	2,770 -20,005	-88%	-$1.83M	﹤0.01%	1773
2026 Q1	$844K	Sell	22,775 -9,185	-29%	-$294K	0.01%	1000
2025 Q4	$645K	Buy	31,960 +18,024	+129%	+$436K	0.01%	973
2025 Q3	$420K	Buy	+13,936	New	+$302K	﹤0.01%	1382

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brevan Howard Capital Management's AEHR Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Aehr Test Systems (AEHR) stake by 88% in Q2 2026, selling an estimated $1.83M and leaving 2,770 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Brevan Howard Capital Management first reported a position in AEHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $844K in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Brevan Howard Capital Management held 2,770 shares of Aehr Test Systems worth $266K as of Q2 2026.
Brevan Howard Capital Management sold 20,005 Aehr Test Systems shares in Q2 2026, an estimated $1.83M.
Aehr Test Systems made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1773 holding.
Brevan Howard Capital Management first reported a position in Aehr Test Systems in Q3 2025 and has held it in 4 quarters since.
Brevan Howard Capital Management's Aehr Test Systems position peaked at $844K in Q1 2026.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.